Omega Healthcare Investors INC Form 4 insider transactions
NYSE
Omega Healthcare Investors CEO C. Taylor Pickett filed an amended Form 4 to correct a typographical error regarding the redemption price of 200,000 OP Units and a related short-swing profit payment.
NYSE
Omega Healthcare Investors CFO Robert O. Stephenson transferred 31,426 shares of common stock to a revocable trust for estate planning purposes.
NYSE
Omega Healthcare Investors' Chief Investment Officer, Vikas Gupta, converted various performance and time-based equity awards into common stock equivalents.
NYSE
Omega Healthcare Investors' Chief Accounting Officer, Neal Ballew, reported routine acquisitions of common stock via ESPP and conversions of Profits Interest Units into OP Units.
NYSE
Omega Healthcare Investors President Matthew Gourmand reported the vesting of over 39,000 performance and time-based equity units into common stock equivalents.
NYSE
Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors, Inc., reported the vesting and conversion of Profits Interest Units into OP Units and subsequently into common stock, effective December 31, 2025.
NYSE
Omega Healthcare Investors CFO Robert O. Stephenson reported a gift of 3,850 common shares and the vesting and conversion of various performance and time-based equity awards.
NYSE
Omega Healthcare Investors CEO C. Taylor Pickett reported the redemption of 200,000 OP Units and the vesting of over 190,000 Profits Interest Units into OP Units.
NYSE
Omega Healthcare Investors' Chief Investment Officer, Vikas Gupta, purchased 11,500 shares of common stock for approximately $42.97 per share.
NYSE
Omega Healthcare Investors CEO C. Taylor Pickett purchased 20,000 shares of company common stock for over $860,000.
NYSE
Omega Healthcare Investors' CFO, Robert O. Stephenson, converted performance-based equity awards into common stock, reflecting the vesting of Profits Interest Units and OP Units.
NYSE
Omega Healthcare Investors CEO C. Taylor Pickett converted 123,081 Profits Interest Units into Operating Partnership Units on September 30, 2025.
NYSE
Omega Healthcare Investors' Chief Legal Officer, Gail D. Makode, converted 23,669 Profits Interest Units and 23,669 OP Units into common stock on September 30, 2025.
NYSE
Omega Healthcare Investors' Chief Investment Officer, Vikas Gupta, converted 23,669 Profits Interest Units into OP Units following performance-based vesting.
NYSE
Omega Healthcare Investors' President, Matthew Gourmand, reported the vesting and conversion of performance-based equity units into OP Units.
NYSE
Omega Healthcare Investors' Chief Accounting Officer, Neal Ballew, reported recent acquisitions and dispositions of company stock and the vesting of performance-based equity units.
NYSE
Omega Healthcare Investors' CFO, Robert O. Stephenson, filed a Form 4 indicating a planned gift of 800 common shares on August 26, 2025, under a Rule 10b5-1 plan.
NYSE
Omega Healthcare Investors Director Lisa Egbuonu-Davis sold a total of 2,500 shares of common stock for approximately $100,393 on August 8, 2025.
NYSE
Omega Healthcare Investors Inc.'s Chief Financial Officer, Robert O. Stephenson, converted 52,396 performance-based units into common stock, reflecting the vesting of long-term incentive awards.
NYSE
Omega Healthcare Investors Inc. CEO C. Taylor Pickett converted 123,081 Profits Interest Units into Operating Partnership Units and subsequently into Common Stock equivalents, reflecting the vesting of performance-based awards.
NYSE
Omega Healthcare Investors' Chief Legal Officer, Gail D. Makode, reported the vesting and conversion of performance-based equity units into OP Units and common stock equivalents, effective June 30, 2025.
NYSE
Vikas Gupta, Chief Investment Officer of Omega Healthcare Investors, converted performance-based Profits Interest Units into OP Units, and subsequently OP Units into common stock equivalents, as part of his compensation plan.
NYSE
Matthew P. Gourmand, President of Omega Healthcare Investors Inc., reported the vesting of over 23,000 Profits Interest Units into OP Units, tied to performance metrics and future redemption options.
NYSE
Neal Ballew, Chief Accounting Officer of Omega Healthcare Investors Inc., reported recent acquisitions of common stock through an employee plan and the vesting of performance-based equity units.
NYSE
Kapila K. Anand, a Director at Omega Healthcare Investors Inc., has been granted 6,150 Deferred Stock Units as part of their annual compensation, increasing their total beneficial ownership to 42,405 units.
NYSE
Omega Healthcare Investors Inc. director Burke W. Whitman was granted 4,388 shares of common stock as compensation, increasing his beneficial ownership to 44,153 shares.
NYSE
Omega Healthcare Investors Inc. Director Stephen D. Plavin reported the vesting and conversion of 4,641 Profits Interest Units into common stock, alongside the grant of 4,424 new Profits Interest Units.
NYSE
Lisa Egbuonu-Davis, a Director at Omega Healthcare Investors Inc., was granted 4,388 shares of common stock as compensation, increasing her total beneficial ownership to 21,154 shares.
NYSE
Omega Healthcare Investors Inc. Director Barbara B. Hill has reported the acquisition of new Profits Interest Units and the conversion of existing equity awards into common stock, as detailed in a recent SEC Form 4 filing.
NYSE
Kevin J. Jacobs, a Director at Omega Healthcare Investors Inc., was granted 7,114 shares of common stock as compensation, valued at $37.6 per share, which will vest in approximately one year.